Cannabidiol suppresses 3-dimensional ovarian cancer growth and may enhance potency of classic and epigenetic therapies
Over an extended kinetic, high and medium concentrations of one time CBD (CBDH) tended to stunt spheroid growth…
Over an extended kinetic, high and medium concentrations of one time CBD (CBDH) tended to stunt spheroid growth…
Abstract Background:Â We previously reported that cannabidiol (CBD), a cannabinoid with a low toxicity profile, downregulated the expression of…
Abstract Recently, cannabinoids, such as cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC), have been the subject of intensive research and…
Abstract Glioma is the most common primary malignant brain tumor with poor survival and limited therapeutic options. The…
Abstract Radiotherapy combined with chemotherapy is the major treatment modality for human glioblastoma multiforme (GBM). GBMs eventually relapse…
Abstract According to recent studies, Cannabidiol (CBD), one of the main components of Cannabis sativa, has anticancer effects in…
Abstract Glioblastoma is the most common primary brain tumor in adults. While the introduction of temozolomide chemotherapy has…
Abstract The main chemical component of cannabis, cannabidiol (CBD), has been shown to have antitumor properties. The present…
Highlights Keywords: Cannabidol, Laetrile, Low grade ovarian cancer, Complimentary alternative medicine Introduction Low grade serous ovarian cancer (LGSOC)…
Abstract Glioblastoma multiforme (GBM) is the most common and aggressive form of primary malignant brain tumor in adults,…